Treatment of early stage of the follicular lymphoma by means of IF radio-therapy in combination with Rituximab

被引：0
|
作者：
Schmaus, M. C. [1 ]
Hensel, M. [1 ]
Herfarth, K. [1 ]
机构：
[1] Heidelberg Univ, Heidelberg, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2008年 / 184卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [41] ECONOMIC ANALYSIS OF RITUXIMAB In Combination with Cyclophosphamide, Vincristine and Prednisolone in the Treatment of Patients with Advanced Follicular Lymphoma in Portugal
    Braga, Paula
    Carvalho, Susana
    Gomes, Marilia
    Guerra, Lurdes
    Lucio, Paulo
    Marques, Herlander
    Negreiro, Filipa
    Pereira, Catarina
    Silva, Catarina
    Teixeira, Adriana
    ACTA MEDICA PORTUGUESA, 2010, 23 (06): : 1025 - 1034
  • [42] Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma
    Laila König
    Klaus Herfarth
    Juliane Hörner-Rieber
    Sascha Dietrich
    Thomas Wiegel
    Jürgen Debus
    Andreas Viardot
    Strahlentherapie und Onkologie, 2020, 196 : 705 - 714
  • [43] Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma
    Koenig, Laila
    Herfarth, Klaus
    Hoerner-Rieber, Juliane
    Dietrich, Sascha
    Wiegel, Thomas
    Debus, Juergen
    Viardot, Andreas
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (08) : 705 - 714
  • [44] Is rituximab maintenance therapy useful following rituximab salvage in refractory or relapsed follicular lymphoma?
    Ritchie, David
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (07): : 402 - 403
  • [45] Is rituximab maintenance therapy useful following rituximab salvage in refractory or relapsed follicular lymphoma?
    David Ritchie
    Nature Clinical Practice Oncology, 2007, 4 : 402 - 403
  • [46] Rituximab As First-Line Maintenance Therapy Following Rituximab-Containing Therapy for Follicular Lymphoma
    Croxtall, Jamie D.
    DRUGS, 2011, 71 (07) : 885 - 895
  • [47] Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma
    Boland, A.
    Bagust, A.
    Hockenhull, J.
    Davis, H.
    Chu, P.
    Dickson, R.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 41 - 48
  • [48] Rituximab With or Without Bevacizumab for the Treatment of Patients With Relapsed Follicular Lymphoma
    Hainsworth, John D.
    Greco, F. Anthony
    Raefsky, Eric L.
    Thompson, Dana S.
    Lunin, Scott
    Reeves, James, Jr.
    White, Lynn
    Quinn, Raven
    DeBusk, Laura M.
    Flinn, Ian W.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (04): : 277 - 283
  • [49] Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma
    Franz Buchegger
    Oliver W Press
    EJNMMI Research, 1
  • [50] Fludarabine, Cyclophosphamide and Rituximab As First Line Treatment In Follicular Lymphoma
    Vicente, Fatima de la Cruz
    Cruz, Estrella Carrillo
    Rodriguez, Maria Sole
    Niebla, Ana Marin
    Herranz, Eduardo Rios
    Galiana, Maria Luz Martino
    Gonzalez, Jose Falantes
    Cuadrado, Isabel Montero
    Campos, Jose Gonzalez
    Tocino, Ildefonso Espigado
    Perez-Simon, Jose A.
    BLOOD, 2013, 122 (21)
12345